Symbol="XERS"
AssetType="Common Stock"
Name="Xeris Pharmaceuticals Inc"
Description="Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois."
CIK="1867096"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="180 N. LASALLE STREET, SUITE 1600, CHICAGO, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="321694000"
EBITDA="-42287000"
PERatio="None"
PEGRatio="None"
BookValue="0.099"
DividendPerShare="0"
DividendYield="0"
EPS="-0.51"
RevenuePerShareTTM="0.981"
ProfitMargin="-0.533"
OperatingMarginTTM="-0.407"
ReturnOnAssetsTTM="-0.105"
ReturnOnEquityTTM="-1.631"
RevenueTTM="134073000"
GrossProfitTTM="87614000"
DilutedEPSTTM="-0.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.502"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.849"
PriceToBookRatio="3.409"
EVToRevenue="2.362"
EVToEBITDA="-2.101"
Beta="1.81"
num_52WeekHigh="3.07"
num_52WeekLow="0.97"
num_50DayMovingAverage="2.485"
num_200DayMovingAverage="1.915"
SharesOutstanding="138066000"
DividendDate="None"
ExDividendDate="None"
symbol="XERS"
open="2.31"
high="2.34"
low="2.27"
price="2.29"
volume="611453.00"
latest_trading_day="2023-08-30"
previous_close="2.33"
change="-0.04"
change_percent="-1.7167%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="80"
Volume_recent_avg="1174097"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="80"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="128"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0048.jpeg"
image_negative_thumbnail_id_2="121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="990"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_positive_thumbnail_id_2="691"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
